Why Your Snoring Could Signal a Hidden Sleep Apnea Threat
Why Your Snoring Could Signal a Hidden Sleep Apnea Threat
Why Your Snoring Could Signal a Hidden Sleep Apnea Threat
Snoring may seem harmless, but it can indicate underlying issues such as obstructive sleep apnea. This condition causes oxygen levels to drop and blood pressure to rise, increasing the risk of cardiovascular issues over time. It also leads to chronic fatigue, poor concentration, and a lower quality of life.
Snoring itself is not always dangerous, but it can point to potential health problems. Experts suggest lifestyle changes to reduce risks. Losing 5-10% of body weight, quitting smoking, and cutting back on alcohol can help. Sleeping on one's side, keeping bedroom humidity balanced, and doing throat exercises may also ease symptoms.
No recent studies in Russia provide exact numbers on how many people suffer from sleep-related breathing disorders. However, the potential health consequences remain a concern for medical professionals.
Addressing snoring and sleep apnea early can lower long-term health risks. Simple adjustments to daily habits and sleep routines may improve breathing and overall health. Without intervention, the condition can lead to lasting damage to both physical and mental health.
Garlic, Vitamin C, and Chlorophyll Team Up for Heart Health Breakthrough
Could a simple blend of garlic, vitamin C, and chlorophyll be the key to a healthier heart? New findings reveal surprising benefits for blood pressure and beyond.
Chuck Norris, 86, hospitalized after medical emergency in Hawaii
From Walker, Texas Ranger to recent films, Norris never slowed down—until now. Fans worldwide await news after his sudden hospitalization.
Blood Test Breakthrough Could Detect Hidden Artery Disease Years Earlier
A simple blood test could soon reveal invisible plaque buildup—long before it triggers a deadly event. Machine learning cracked the code in 45,000 patients' data.
Eli Lilly's retatrutide shows groundbreaking results in Type 2 diabetes trial
A triple-hormone drug could redefine diabetes care. Early data shows retatrutide outperforms competitors—but will regulators agree?